Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001855763-22-000019)

Filing Details

Accession Number:: 0001855763-22-000019
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2022-10-18 18:20:31
Reporting Period:: 2022-10-12

Accepted Time:: 2022-10-18 18:20:31
Original Submission Date:: 2022-10-13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1348362	Lexaria Bioscience Corp.	LEXX	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1103780	Christopher Bunka	1924 Birkdale Ave Kelowna A1 V1P1R7	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2022-10-12	21,900	$1.99	237,812	No	4	P	Indirect	Private Holding Company
Common Shares	Acquisiton	2022-10-13	16,600	$2.10	254,412	No	4	P	Indirect	Private Holding Company

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Private Holding Company
No	4	P	Indirect	Private Holding Company

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	273,543	Direct
Common Shares	215,912	Indirect	Private Holding Company

Footnotes

This Form 4/A is being filed to correct the transaction code for the open market purchase of common shares made by Mr. Bunka as previously notated as a grant or award in the Form 4 originally filed on 10/13/2022.